Cargando…

Preparation and characterization of erythrocyte membrane cloaked PLGA/arsenic trioxide nanoparticles and evaluation of their in vitro anti-tumor effect

Arsenic trioxide (ATO) is used for acute promyelocytic leukemia (APL) that is resistant to all-trans-retinoic acid, but its direct intravenous injection sometimes induces severe toxic side effects. Here, we developed a delivery system of red blood cell membrane (RBCM) cloaked poly (lactic-co-glycoli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Jing, Liu, Geyi, Lian, Yumei, Kamal, Zul, Que, Xiao, Qiu, Yujiao, Qiu, Mingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080777/ https://www.ncbi.nlm.nih.gov/pubmed/35541656 http://dx.doi.org/10.1039/c8ra01417e

Ejemplares similares

Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles
por: Su, Jing, et al.
Publicado: (2019)

Erythrocyte Membrane-Coated Arsenic Trioxide-Loaded Sodium Alginate Nanoparticles for Tumor Therapy
por: Lian, Yumei, et al.
Publicado: (2019)

Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles
por: Que, Xiao, et al.
Publicado: (2019)

Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy
por: Xie, Xiaotian, et al.
Publicado: (2019)

Nanoparticle biointerfacing via platelet membrane cloaking
por: Hu, Che-Ming J., et al.
Publicado: (2015)

Self-activated in vivo therapeutic cascade of erythrocyte membrane-cloaked iron-mineralized enzymes
por: Liu, Wen, et al.
Publicado: (2020)

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma
por: Cui, Yuexin, et al.
Publicado: (2020)

Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019)

Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy
por: Wu, Xinyi, et al.
Publicado: (2021)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases
por: Fang, Zhengyu, et al.
Publicado: (2022)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Field-programmable silicon temporal cloak
por: Zhou, Feng, et al.
Publicado: (2019)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

Biocompatible Assessment of Erythrocyte Membrane-Camouflaged Polymeric PLGA Nanoparticles in Pregnant Mice: Both on Maternal and Fetal/Juvenile Mice
por: Chen, Sailing, et al.
Publicado: (2022)

Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers
por: Akhtar, Anam, et al.
Publicado: (2017)

Engineering Cell Membrane‐Cloaked Catalysts as Multifaceted Artificial Peroxisomes for Biomedical Applications
por: Yang, Dongmei, et al.
Publicado: (2023)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
por: Lee, Na-Hyun, et al.
Publicado: (2022)

Preparation and Characterization of Anti-Cancer Crystal Drugs Based on Erythrocyte Membrane Nanoplatform
por: Ren, Lili, et al.
Publicado: (2021)

Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency
por: Wang, Shaoning, et al.
Publicado: (2020)

Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung.
por: Ishinishi, N, et al.
Publicado: (1977)

Mortality experience in relation to a measured arsenic trioxide exposure
por: Pinto, Sherman S., et al.
Publicado: (1977)

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
por: Sertel, Serkan, et al.
Publicado: (2012)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
por: Udensi, Udensi K, et al.
Publicado: (2011)

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats
por: Zhang, Weiqian, et al.
Publicado: (2014)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cbopju8hgvk0jd47rn2faq9skc